Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selected strategies to augment polynucleotide immunization

R M Conry1, G Widera, A F LoBuglio

  • 1Gene Therapy Program, Department of Medicine, University of Alabama at Birmingham, USA.

Gene Therapy
|January 1, 1996
PubMed
Summary

Co-delivering complementary DNA (cDNA) encoding immune-boosting molecules via a single plasmid enhances anti-tumor immune responses. This strategy, utilizing co-expression within cells, improves antibody production and anti-tumor effects for polynucleotide immunization.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimization of a support vector regression model predicts maximal weight lifted during a manual material handling assessment within a military setting.

Applied ergonomics·2026
Same author

A markerless motion capture system can reliably determine peak trunk flexion while squatting with and without a weighted vest.

Journal of biomechanics·2023
Same author

Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred.

The journal of prevention of Alzheimer's disease·2019
Same author

Asymmetry during Functional Movement Screening and injury risk in junior football players: A replication study.

Scandinavian journal of medicine & science in sports·2017
Same author

Augmented adenovirus transduction of murine T lymphocytes utilizing a bi-specific protein targeting murine interleukin 2 receptor.

Cancer gene therapy·2015
Same author

Gene therapy for radioprotection.

Cancer gene therapy·2015

Area of Science:

  • Immunology
  • Molecular Biology
  • Vaccine Development

Background:

  • Polynucleotide immunization enhances immune responses by delivering DNA encoding antigens.
  • Co-delivery of complementary DNA (cDNA) encoding cytokines or co-stimulatory molecules can augment immune responses.
  • Antigen-presenting cells, like Langerhans cells, play a crucial role in immune responses to vaccination.

Purpose of the Study:

  • To enhance immune responses to polynucleotide immunization through co-delivery of cDNA.
  • To investigate the effectiveness of co-delivering cDNA for B7-1 and carcinoembryonic antigen (CEA) via intramuscular immunization.
  • To evaluate the impact of granulocyte-macrophage colony stimulating factor (GM-CSF) delivered by particle bombardment on cutaneous immunization.

Main Methods:

Related Experiment Videos

  • Co-delivery of cDNA for B7-1 and CEA using a dual expression plasmid or separate plasmids via intramuscular injection.
  • Comparison of immune responses generated by dual plasmid delivery versus single antigen plasmid delivery.
  • Administration of plasmid DNA encoding GM-CSF via particle bombardment prior to CEA DNA immunization.

    • Main Results:

    • The dual expression plasmid co-delivering B7-1 and CEA resulted in superior anti-CEA antibody responses and anti-tumor effects compared to CEA DNA alone.
    • Co-delivery of separate plasmids encoding B7-1 and CEA did not augment the immune response.
    • Co-delivery of GM-CSF via particle bombardment enhanced CEA-specific lymphoblastic transformation and antibody response.

    Conclusions:

    • Single plasmid delivery is crucial for effective co-expression and augmentation of immune responses.
    • Co-expression of B7-1 and CEA within the same cell enhances antigen presentation and immune outcomes.
    • GM-CSF delivered via particle bombardment can enhance the antigen-presenting capacity of skin-resident cells, improving vaccine efficacy.